期刊文献+

射频消融治疗对残癌细胞增殖能力的影响 被引量:2

Proliferative capability of remnant hepatic VX2 tumor in rats after treatment with radio frequency ablation
原文传递
导出
摘要 目的探讨射频消融(radio frequency ablation,RFA)治疗后残余肿瘤细胞的增殖情况。方法VX2肿瘤组织块接种于新西兰兔肝脏,建立种植型肝脏肿瘤模型,2周后行RFA治疗,通过控制肿瘤边缘的温度,人为造成肿瘤残余。实验动物分实验组及对照组,实验组动物脾脏接种残癌组织,对照组动物脾脏接种未经RFA处理的VX2肿瘤组织,术后2、3、4周观察脾脏肿瘤体积、质量并测定肿瘤细胞的增殖指数。结果术后2周对照组肿瘤体积、质量大于实验组;术后3、4周两组间肿瘤体积及质量比较差异无统计学意义;术后2、3、4周肿瘤细胞的增殖指数无差别。结论射频消融治疗对残余肿瘤细胞的增殖无明显影响。 Objective To observe the changes of proliferative capability of remnant hepatic VX2 tumor after treatment with radio frequency ablation (RFA) . Methods Rabbit hepatoma models were established by implanting VX2 tumor mass into the liver of New Zealand rabbits. RFA was applied to the tumors and the remnant tumors were harvested by controlling the marginal temperature of the tumors. The rabbits were divided into treatment group and control group. The spleens of the rabbits in the treatment group were implanted with remnant tumor tissue, while those in the control group with the VX2 tumors tissue without being processed by RFA. Volume, weight and proliferation index (PI) of the tumors were compared between the two groups 2, 3 and 4 weeks after RFA. Results The mean levels of volume and weight of the tumors were (278.28 ± 55.77 ) mm and ( 3. 0. 31 ± 0. 07 ) mg in control group, which were significantly higher than ( 100.32 ± 25.52) mm and ( 3. 0. 12 ± 0. 10 ) mg respectively in treatment group at weeks 3, 4 postoperatively, while they showed no statistical difference between the two groups at week 3, 4 postoperatively. There was no statistical difference upon the PI between the groups at weeks 2, 3 and 4 postoperatively. Conclusion RFA has no apparent effect on proliferative capability of VX2 tumor cells.
出处 《中华消化外科杂志》 CAS CSCD 2007年第3期224-226,共3页 Chinese Journal of Digestive Surgery
关键词 射频消融 肿瘤增殖 Radio frequency ablation Tumor proliferation
  • 相关文献

同被引文献33

  • 1陈健,李大江,王曙光.腺病毒介导凋亡素基因对人胆管癌细胞凋亡的研究[J].中华消化外科杂志,2007,6(4):294-298. 被引量:2
  • 2Kim CY, Park SH, Jeong M, et al. Preclinical studies for pharmacokinetics and biodistribution of Ad -stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy [J]. Experimental & molecular medicine, 2011, 43 (10):580-586.
  • 3Kim MH, Billiar TR, Seol DW. The secretable form of trimeric TRAIL a potent inducer of apoptosis[J]. Biochemical and Biophysical Research Communications, 2004,321 (4):930-935.
  • 4Li W, Ma N, Ong LL, Nesselmann C, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function[J]. Stem Cells, 2007, 25(8):2118-2127.
  • 5Huang J, Li T, Liu N, et al. Safety and reliability of hepatic radiofrequency ablation near the inferior vena cava: an experimental study[J]. International journal of hyperthermia : the official journal of European Society for Hyperthernlic Oncology, North American Hyperthermia Group, 2011, 27(2):116-123.
  • 6Liu N, Gao J, Liu Y, et al. Determining a minimal safe distance to prevent thermal injury to intrahepatic bile ducts in radiofrequency ablation of the liver: a study in dogs [J]. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2012,28 (3):210-217.
  • 7Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J]. Journal of hepatology, 2012,57 (4):794-802.
  • 8Carnaghi C, Troneoni MC, Rimassa L, et al. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy[J]. Nuclear medicine review Central & Eastern Europe, 2007,10( 1 ): 12-15.
  • 9Lendoire JC, Gil L, Duek F, et al. Relevance of residual disease after liver resection for incidental gallbladder cancer[J]. HPB : the official journal of the International Hepato Pancreato Biliary Association, 2012,14(8):548-553.
  • 10Gao T, Li N, Zhang JJ, et al. Restricted intravenous fluid regimen reduces the rate of postoperative complications and alters immunological activity of elderly patients operated for abdominal cancer: a randomized prospective clinical trail[J]. World journal of surgery, 2012,36 (5) :993-1002.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部